Predictors of long-term compliance with continuous positive airway pressure
- 1Sleep Disorders Centre and Pulmonary Division, University Hospital Zurich, Switzerland
- 2Sleep Unit, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK
- Correspondence to Dr Malcolm Kohler, Sleep Disorders Centre and Pulmonary Division, University Hospital of Zurich, Raemistrasse 100, 8091 Zurich, Switzerland; malcolm.k{at}bluewin.ch
- Received 25 January 2010
- Accepted 26 June 2010
Abstract
Background There are very few data on objectively assessed long-term compliance with continuous positive airway pressure (CPAP). No single factor has been consistently identified as predictive of continued CPAP use.
Methods Adherence to and associations with objective CPAP use were examined in 639 of 3900 patients in whom CPAP treatment was started between 1994 and 2005. Kaplan–Meier survival analyses were used to estimate the proportion of patients still on CPAP. Cox regression models were used to explore the effects of covariates on continued use of CPAP.
Results The median (IQR) follow-up time after initiating CPAP therapy was 3.9 (1.5–6.9) years and the average use of CPAP was 6.2 (4.5–7.3) h/night. The percentage of patients adherent to CPAP after 5 and 10 years was 81% and 70%, respectively. Multivariate analysis, including gender, age, neck circumference, Epworth Sleepiness Score, oxygen desaturation index (ODI) and research study participation, indicated that ODI was the only clinical variable independently associated with long-term adherence to CPAP (HR per 1 event=0.97, p<0.001, 95% CI 0.96 to 0.98). ODI categories were significantly associated with the risk for stopping CPAP in multivariate analysis (using ODI group 0–15/h as reference, HR for ODI group >15–30/h=0.68, p=0.100, 95% CI 0.43 to 1.08; for ODI group >30–60/h=0.37, p<0.001, 95% CI 0.22 to 0.60; and for ODI group >60/h=0.17, p=0.001, 95% CI 0.06 to 0.48).
Conclusions The majority of patients with sleep-disordered breathing are using CPAP in the long term and the severity of sleep-disordered breathing rather than sleepiness determines long-term adherence to CPAP therapy.
Footnotes
-
Funding MK is a recipient of a European Respiratory Society (No 118) and University of Zurich, Switzerland, research fellowship.
-
Competing interests None.
-
Ethics approval This study was conducted with the approval of the Oxford research ethics committee.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- Received 25 January 2010
- Accepted 26 June 2010








